Search

ProQR Announces R&D Day in New York on June 15

Press release

Key updates:

mei 09, 2017
ProQR to Participate in 8th Annual Evercore Healthcare Conference

Press release

LEIDEN, Netherlands & CAMBRIDGE, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V.

december 01, 2025
ProQR Announces R&D Day and Provides Update on Innovation Portfolio

Press release

First Investor R&D Day on March 14, 2016 in New York, NY

november 30, 2015
ProQR Prices $50 Million Underwritten Public Offering of Ordinary Shares

Press release

LEIDEN, The Netherlands and CAMBRIDGE, Mass., Oct. 15, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V.

oktober 16, 2019
ProQR Appoints Naveed Shams, MD, PhD as Chief Scientific Officer

Press release

Proven leader with deep worldwide ophthalmology experience, including multiple approvals globally

oktober 05, 2020
ProQR to Present at Scientific and Investor Conferences in September

Press release

LEIDEN, the Netherlands, Sept. 06, 2016 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V.

september 06, 2016
ProQR to Present at Upcoming JMP Securities Life Sciences Conference

Press release

LEIDEN, Netherlands & CAMBRIDGE, Mass., June 10, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V.

juni 10, 2021
ProQR Announces Conference Call to Discuss Axiomer® RNA Editing Platform

Press release

LEIDEN, Netherlands & CAMBRIDGE, Mass., Dec. 22, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V.

december 22, 2022
ProQR to Present at Upcoming Scientific Meeting and Investor Conference

Press release

LEIDEN, the Netherlands, Feb. 06, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V.

februari 06, 2018
ProQR Announces Financial Results for the Third Quarter of 2018

Press release

… ProQR Announces Financial Results for the Third Quarter of … LCA10,” said Daniel A. de Boer, chief executive officer of ProQR. “These results build confidence in QR-110 and the … for QR-110 in patients with LCA10 and preclinical data for ProQR’s Axiomer ® RNA-editing technology. Abstract titles: …

november 07, 2018